An NHS clinical scientist has won support to develop a voice-controlled data collection app for patients with sickle cell disease.
Bala Sirigireddy, head of haematology and blood transfusion at Homerton University Hospital Foundation trust, London, is one of five healthcare scientists to be appointed to the NHS England Clinical Entrepreneurs Programme.
The scientists are among 138 entrepreneurs selected to take part in the programme which will allow NHS staff to work with leading health and technology industry experts in developing their ideas.
With a background in both software development and clinical science, Sirigireddy is developing a voice-controlled data collection app which can be worn by patients to monitor their heart rate, pain score and log daily medication.
He said: “I see the clinical entrepreneur programme as an amazing opportunity to make national and international level impact in improving healthcare. To be able to innovate new products/services and pathways with the guidance from NHS England is incredible.
“This unique opportunity facilitates networking with like-minded entrepreneurs and industry experts, who are all eager to exchange ideas and make meaningful impact in health service.”
Chief scientific officer Professor Sue Hill said: “Giving budding entrepreneurs in the NHS support and space to create new solutions to old problems will keep the NHS at the forefront of innovation in healthcare.
“I’m delighted to see even more of our staff join the Clinical Entrepreneurs programme, which will see nearly 140 doctors, nurses and scientists benefit from world-class industry expertise, even as they continue to deliver care for patients.”
Disclaimer: The news stories shared on this site are used as a way to inform our members and followers of updates and relevant information happening in Haematology. The BSH does not endorse the content of news items from external sources, and is not in a position to verify the findings, accuracy or the source of any studies mentioned. Any medical or drugs information is provided as an information resource only, and is not to be relied on for any diagnostic or treatment purposes.
News service provided by Englemed News http://www.englemed.co.uk/